sec filing
CU
NASDAQ · CURX
Curanex Pharmaceuticals Inc Common Stock
Healthcare · Biotechnology
$6.19
Down-$0.39 (-6.30%)
Updated Nov 5, 2026, 12:01 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.53M
- P/E ratio
- -9.14
- Dividend yield
- 0.00%
- 52-week range
- $0.18 – $6.80
- Volume
- 10.97K
- Avg. volume
- 1.52M
Price performance · CURX
CURX price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
CURX closed at $6.19 after 19 trading sessions, up 29.77% for the selected period.
- Last close
- $6.19
- Period change
- +29.77%
- Period low
- $4.60
- Period high
- $6.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $5.80 | $6.20 | $5.80 | $6.19 | 10.97K |
| Nov 2, 2026 | $5.47 | $5.8521 | $5.40 | $5.85 | 3.35K |
| Oct 30, 2026 | $5.08 | $5.355 | $5.08 | $5.16 | 9.23K |
| Oct 29, 2026 | $4.38 | $5.64 | $4.38 | $4.94 | 70.86K |
| Oct 28, 2026 | $5.045 | $5.045 | $4.80 | $4.95 | 8.81K |
| Oct 27, 2026 | $4.75 | $4.80 | $4.75 | $4.7649 | 2.22K |
| Oct 26, 2026 | $4.70 | $5.00 | $4.6001 | $4.6001 | 13.51K |
| Oct 23, 2026 | $4.81 | $4.9389 | $4.501 | $4.64 | 7.79K |
| Oct 22, 2026 | $4.99 | $5.59 | $4.98 | $5.20 | 4.84K |
| Oct 21, 2026 | $4.7501 | $5.01 | $4.69 | $5.01 | 5.03K |
| Oct 20, 2026 | $4.65 | $5.02 | $4.5416 | $4.765 | 7.52K |
| Oct 19, 2026 | $4.62 | $4.99 | $4.62 | $4.92 | 6.73K |
| Oct 16, 2026 | $4.85 | $4.9455 | $4.6144 | $4.62 | 10.68K |
| Oct 15, 2026 | $4.87 | $5.19 | $4.75 | $4.83 | 15.98K |
| Oct 14, 2026 | $4.4009 | $4.9999 | $4.31 | $4.96 | 9.09K |
| Oct 12, 2026 | $5.04 | $5.17 | $4.88 | $4.88 | 7.9K |
| Oct 9, 2026 | $4.61 | $5.31 | $4.61 | $5.31 | 17.09K |
| Oct 8, 2026 | $4.75 | $4.90 | $4.51 | $4.76 | 14.42K |
| Oct 7, 2026 | $4.79 | $5.15 | $4.45 | $4.77 | 102.01K |
Latest CURX news
The latest Smart Investors Daily articles mentioning CURX.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…